How We Do Harm exposes the underbelly of healthcare today—the overtreatment of the rich, the under treatment of the poor, the financial conflicts of interest that determine the care that physicians’ provide, insurance companies that don’t demand the best (or even the least expensive) care, and pharmaceutical companies concerned with selling drugs, regardless of whether they improve health or do harm.
Dr. Otis Brawley is the chief medical and scientific officer of The American Cancer Society, an oncologist with a dazzling clinical, research, and policy career. How We Do Harm pulls back the curtain on how medicine is really practiced in America. Brawley tells of doctors who select treatment based on payment they will receive, rather than on demonstrated scientific results; hospitals and pharmaceutical companies that seek out patients to treat even if they are not actually ill (but as long as their insurance will pay); a public primed to swallow the latest pill, no matter the cost; and rising healthcare costs for unnecessary—and often unproven—treatments that we all pay for. Brawley calls for rational healthcare, healthcare drawn from results-based, scientifically justifiable treatments, and not just the peddling of hot new drugs.
Brawley’s personal history – from a childhood in the gang-ridden streets of black Detroit, to the green hallways of Grady Memorial Hospital, the largest public hospital in the U.S., to the boardrooms of The American Cancer Society—results in a passionate view of medicine and the politics of illness in America – and a deep understanding of healthcare today. How We Do Harm is his well-reasoned manifesto for change.
Study provides much needed information for parents or clinicians on the relative risks of modern IVF treatments
Children born after certain infertility treatments are at higher risk of autism, and all IVF treatments carry a slightly heightened risk of low intelligence later in life than natural births, a major study has shown.
However, scientists stressed that the chances of an IVF baby being affected was tiny in real terms.
Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
Carrying out a virus test before traditional cervical screening could prevent around 600 cases of cancer a year in England, research suggests. Scientists found that more than 40% of 8,750 women with cervical cancer had received a negative screening test result within six years of their diagnosis. They then predicted how many more cases of cervical cancer would have been avoided if human papilloma virus (HPV) testing had been used ahead of screening for abnormal cells.
Many women have to take medicines while pregnant. But could they be risking the health of their unborn child? Decades after the Thalidomide scandal shocked the world, Panorama reveals how another medicine has damaged far more children. Drugs cannot be tested on pregnant women for ethical reasons, so doctors do not know if most prescription drugs are safe for the unborn child, and the system set up to monitor side-effects appears to be flawed. As evidence emerges that some common antidepressants are linked to heart defects in babies, the programme asks how much we really know about the safety of medicines women take while pregnant
The program is very interesting but unfortunately does not mention the DES drug tragedy. Once again DES is ignored. WHY? It would have been such a great opportunity. What’s wrong with DES? Is it because with DES, the Media can’t show upsetting photos of children born with no arms or legs like the victims of Thalidomide, or newborn babies who have undergone traumatic heart surgery because of the effects associated with the antidepressant drug their mum took during pregnancy? Is it because DES is the very first drug scandal which should have prevented many others to happen? All victims of drugs prescribed during pregnancy should join forces! The stories are all the same and highlights the same failure of our health system and the government response to the devastating consequences of these drugs. DES, Thalidomide, epilepsy drug Epilim, antidepressants … how many more victims are needed to put in place safeguards to protect mothers and their unborn child?
The medical community has become increasingly concerned about the number of women facing age-related infertility. One of the big questions being asked is how we get information about the risks of delaying childbearing into public consciousness? Many women are unaware of how steeply fertility declines for women after reaching age 35, and others are shocked to discover, that not even the most advanced assisted reproductive technologies (ART), can guarantee success for them.